According to the research report titled ‘Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others), by and End-User (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027’, available with MarketStudyReport, global neurorehabilitation market was worth USD 1097.69 billion in 2020 and is anticipated to record a CAGR of 8.3% during 2021-2027 to amass a valuation of 1918.1 billion by the year 2027.
 

As per the report findings, the expansion of global neurorehabilitation market is attributed to rising cases of neurological illnesses. According to the World Health Organization report 2019, depression affected 264 million people worldwide. Whereas, bipolar disorder affected around 45 million people, 20 million people suffered from schizophrenia globally.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566347/
 

For the record, neurorehabilitation is utilized in rehabilitation centers, hospitals, and clinics to treat patients with neurological problems. Parkinson’s disease, brain stroke, multiple sclerosis, traumatic brain injury, spinal cord injury, and cerebral palsy are various conditions which are treated using neurorehabilitation.
 

The growing approval of products by regulatory bodies and increasing investments in research and development activities are expected to boost the industry share during the forecast period. However, high cost of device may hamper the market growth over the forecast period of 2021-2027.
 

Based on product type, the industry is branched into brain-computer interfaces, non-invasive stimulators, and neuro robotic devices. In terms of application ambit of neurorehabilitation market, the industry is divided into Parkinson’s disease, brain stroke, multiple sclerosis, cerebral palsy, traumatic brain injury, spinal cord injury, and others.
 

On the basis of end-user vertical, the marketplace is categorized into hospitals & clinics, and rehabilitation centers.
 

Speaking of regional landscape, Europe market currently holds a significant revenue share, because of the growing geriatric population, the promptness and affordability of neurorehabilitation centers, as well as the well-established healthcare infrastructure, and increasing cases of neurological disorders.
 

Whereas, Asia-Pacific market is expected to grow at a rapid pace between 2021 and 2027, owing to increasing awareness of neurological illnesses, growing population, surging patient pool, improvements in healthcare infrastructure.
 

The key players in worldwide neurorehabilitation market are ReWalk Robotics, Inc., Reha Technology AG, Neuro Rehab VR, Neofect, Eodyne Systems S.L., Ekso Bionics Holdings, Inc., DIH Medical, Bioventus®, Inc., BioScience Managers Pty Ltd., and BIONIK Laboratories Corp.